Gilder Gagnon Howe & Co’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
TS
IAM
MVP
BIT
Gilder Gagnon Howe & Co's PGEN Position: Q2 2016 in Review
Gilder Gagnon Howe & Co sold out of Precigen (PGEN) in Q2 2016, closing a stake of 706 shares — an estimated $24K sold.
Gilder Gagnon Howe & Co first reported a position in PGEN in Q1 2015 and held it in 5 quarters. The position peaked at $10.7M in Q2 2015. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.
- Gilder Gagnon Howe & Co reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
- Gilder Gagnon Howe & Co sold 706 Precigen shares in Q2 2016, an estimated $24K.
- Gilder Gagnon Howe & Co first reported a position in Precigen in Q1 2015 and held it in 5 quarters.
- Gilder Gagnon Howe & Co's Precigen position peaked at $10.7M in Q2 2015.
- 169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.
Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2016, filed 1 Aug 2016.